NK cell-based cancer immunotherapy
- PMID: 17520092
- DOI: 10.1358/dnp.2007.20.3.1092096
NK cell-based cancer immunotherapy
Abstract
The identification of spontaneous antitumor immune responses in cancer patients and the demonstration that an intact immune system can prevent against certain forms of malignancies invigorated research efforts in the development of cancer immunotherapies. To date, numerous and diversified approaches are being investigated, thereby providing new means by which to mobilize the cellular and molecular elements of the immune system in order to destroy established cancers. While it is appreciated that tumor-specific cytotoxic T lymphocytes play a critical role in successful immunotherapy, it is becoming increasingly apparent that cellular components of both the innate and the adaptive arms of the immune system can control tumor growth. In particular, natural killer (NK) cells are emerging as key players in the cross-talk between innate and adaptive immunity. With the uncovering of the regulatory mechanisms governing NK cell biology, new immunotherapies based on the harnessing of NK cell antitumor activity are now being developed. In this review, we summarize the role of NK cells in the control of tumor growth and discuss potential cancer therapies incorporating NK cell-mediated antitumor activity.
Copyright (c) 2007 Prous Science. All rights reserved.
Similar articles
-
Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.Int Rev Immunol. 2008;27(3):93-110. doi: 10.1080/08830180801911743. Int Rev Immunol. 2008. PMID: 18437601 Review.
-
NK cell receptors as tools in cancer immunotherapy.Adv Cancer Res. 2006;95:249-92. doi: 10.1016/S0065-230X(06)95007-6. Adv Cancer Res. 2006. PMID: 16860660 Review.
-
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells].Bull Cancer. 2003 Aug-Sep;90(8-9):699-705. Bull Cancer. 2003. PMID: 14609759 Review. French.
-
Natural killer cell-directed therapies: moving from unexpected results to successful strategies.Nat Immunol. 2008 May;9(5):486-94. doi: 10.1038/ni1580. Nat Immunol. 2008. PMID: 18425105 Review.
-
Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.Cell Death Differ. 2008 Jan;15(1):51-7. doi: 10.1038/sj.cdd.4402243. Epub 2007 Oct 19. Cell Death Differ. 2008. PMID: 17948028 Review.
Cited by
-
Natural killer cells as helper cells in dendritic cell cancer vaccines.Front Immunol. 2015 Jan 28;6:13. doi: 10.3389/fimmu.2015.00013. eCollection 2015. Front Immunol. 2015. PMID: 25674087 Free PMC article. Review.
-
Natural killer cells: role in local tumor growth and metastasis.Biologics. 2012;6:73-82. doi: 10.2147/BTT.S23976. Epub 2012 Apr 5. Biologics. 2012. PMID: 22532775 Free PMC article.
-
Cyclic adenosine monophosphate differentiated beta-endorphin neurons promote immune function and prevent prostate cancer growth.Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9105-10. doi: 10.1073/pnas.0800289105. Epub 2008 Jun 17. Proc Natl Acad Sci U S A. 2008. PMID: 18562281 Free PMC article.
-
3D Immunocompetent Organ-on-a-Chip Models.Small Methods. 2020 Sep 11;4(9):2000235. doi: 10.1002/smtd.202000235. Epub 2020 Jun 17. Small Methods. 2020. PMID: 33072861 Free PMC article.
-
Effects of oral administration of fucoidan extracted from Cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model.Mar Drugs. 2012 Oct;10(10):2337-2348. doi: 10.3390/md10102337. Epub 2012 Oct 22. Mar Drugs. 2012. PMID: 23170088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
